BioWorld MedTech

Nov. 13, 2015

View Archived Issues

Pixium Vision to challenge Second Sight with retinal implant

PARIS — The window is closing for first-to-market mover Second Sight (Sylmar, Calif.) as French start-up Pixium Vision (Paris) prepares a first-in-man trial for its retinal implant Iris-II. Read More

Inside the Beltway: Rates of deficiency letters, pendency up for 2015 PMAs

Read More

Medtronic's tiny, no-lead pacemaker on track for FDA approval in 2016

Read More

Derma dumps DFU trial for futility, exits drug development

Read More

Digisight goes mobile with ophthalmology technology

Read More

Agreements/Contracts: Protagen, Mikrogen agree to co-develop Lyme disease markers

Read More

World in review: Alivecor, C. Illies & Co. in East Asia distribution agreement

Read More

Financings: Optovue snags $30 million investment to drive innovation in OCT eye market

Read More

Product briefs

Read More

Briefly noted

Read More

People in places

Read More

MDD's Diagnostics Extra

Read More